Nimotuzumab Combined With mFOLFIRINOX/GX as Postoperative Adjuvant Therapy in Pancreatic Cancer
Clinical trial NCT06389760 · RECRUITING
Trial details
- NCT number
- NCT06389760
- Sponsor
- The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-18
- Primary completion
- 2026-09-30
- Enrollment
- 57
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.